Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine Contracts + Grants October 15, 2012 …
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution Industry News October 13, 2012 …
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
FDA Grants Priority Review for Multi-Drug Resistant Tuberculosis Treatment Medical Countermeasures September 6, 2012 …
Biodefense BAA Supports Adjuvant Development for Emerging Diseases Contracts + Grants August 16, 2012 …
InBios, UN-Reno Partner to Develop Diagnostic for Melioidosis Medical Countermeasures August 9, 2012 …
